Hydroxocobalamin 1mg/mL

Manufacturer
Xseer Pharmaceuticals
Effective date
2026-05-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-06-03 18:04:17

Label at a glance#

ProductHydroxocobalamin
Active ingredientHYDROXOCOBALAMIN
Label structure7 sections

Storage and handling

Store Hydroxocobalamin Injection at USP Controlled Room Temperature, 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F to 86°F). Protect from light and freezing. Keep vial in carton until use. Inspect solution visually prior to administration. Do not use if the solution is cloudy, discolored, or contains particulate matter. Use aseptic technique when handling and withdrawing product fro...

Label contents#

Full prescribing information#

Desription

DESCRIPTION SECTION

Hydroxocobalamin Injection is a sterile, red-colored, preservative-containing injectable solution supplied as a multi-dose vial for intramuscular administration. Hydroxocobalamin is a naturally occurring form of vitamin B12 essential for normal hematopoiesis, neurologic function, and cellular metabolism.

Each mL contains:

Hydroxocobalamin .............................. 1 mg
Benzyl Alcohol .................................. 0.9%
Sodium Chloride ................................ 9 mg
Sterile Water for Injection .............. q.s.

The pH is adjusted with hydrochloric acid and/or sodium hydroxide to a target pH range of 4.0 to 7.5.

Hydroxocobalamin appears as dark red crystals or crystalline powder and is sparingly soluble in water. The solution should appear clear and red in color.

Storage and Handling

STORAGE AND HANDLING SECTION

Store Hydroxocobalamin Injection at USP Controlled Room Temperature, 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F to 86°F).

Protect from light and freezing. Keep vial in carton until use.

Inspect solution visually prior to administration. Do not use if the solution is cloudy, discolored, or contains particulate matter.

Use aseptic technique when handling and withdrawing product from the multi-dose vial.

Components

Each mL contains Hydroxocobalamin 1 mg as the active pharmaceutical ingredient. Hydroxocobalamin is a naturally occurring form of vitamin B12 used for vitamin B12 replacement therapy and support of normal hematologic and neurologic function.

Benzyl Alcohol 0.9% as preservative

Sodium Chloride 9 mg for isotonicity
Sterile Water for Injection q.s. as solvent vehicle

The pH is adjusted with Hydrochloric Acid and/or Sodium Hydroxide to a pH range of 4.0 to 7.5.

Warnings and Precautions

WARNINGS AND PRECAUTIONS SECTION

Hypersensitivity reactions, including anaphylactic shock, rash, pruritus, urticaria, and edema, have been reported following parenteral administration of vitamin B12 products, including hydroxocobalamin. Patients with known sensitivity to hydroxocobalamin, cobalt, benzyl alcohol, or any component of the formulation may be at increased risk for serious allergic reactions.

This product contains benzyl alcohol as a preservative. Benzyl alcohol has been associated with serious and fatal adverse reactions, including “gasping syndrome,” in premature infants and neonates.

Administer under appropriate medical supervision. Monitor patients for signs and symptoms of hypersensitivity during administration.

Do not use if the solution is cloudy, discolored, or contains particulate matter. Use aseptic technique during handling and administration.

Protect from light. Not for intravenous administration.

Adverse Reactions

ADVERSE REACTIONS SECTION

The following adverse reactions have been reported with hydroxocobalamin injection and other parenteral vitamin B12 products:

Hypersensitivity reactions including anaphylactic shock, urticaria, rash, pruritus, flushing, and edema
Injection site pain, erythema, and injection site reactions
Headache and dizziness
Nausea and diarrhea
Fever and chills
Rare cases of hypokalemia during intensive treatment of severe megaloblastic anemia

Serious hypersensitivity reactions, including anaphylaxis, may occur in sensitive patients.

To report suspected adverse reactions, contact Xseer Pharmaceuticals at (888) 658-8005 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Contraindications

CONTRAINDICATIONS SECTION

Hydroxocobalamin Injection is contraindicated in patients with known hypersensitivity to hydroxocobalamin, vitamin B12 preparations, cobalt, benzyl alcohol, or any component of the formulation.

Hypersensitivity reactions, including anaphylactic shock and serious allergic reactions, have been reported following parenteral administration of hydroxocobalamin and other vitamin B12 products.

Administration to patients with hereditary optic nerve atrophy (Leber’s disease) may result in severe and rapid optic nerve atrophy.

Package Label Principal display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Front labelFront labelHydroxocobalamin Injection
1 mg/mL

For Intramuscular Administration

30 mL Multi-Dose Vial

Rx Only

Sterile, Preservative-Containing Solution

Each mL contains:
Hydroxocobalamin 1 mg, Benzyl Alcohol 0.9%, Sodium Chloride 9 mg, Sterile Water for Injection q.s. pH adjusted with Hydrochloric Acid and/or Sodium Hydroxide.

Store at USP Controlled Room Temperature 20°C to 25°C (68°F to 77°F). Protect from light and freezing.

Compounded by:
Xseer Pharmaceuticals
1990 Westwood Blvd., Suite 300
Los Angeles, CA 90025
Phone: (888) 658-8005

Lot #: __________

Exp. Date: __________

To report suspected adverse reactions, contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
HYDROXOCOBALAMIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 12885551-125-3085551-125-30_Hydroxocobalamin_1mgml_30ml_vial.jpg.jpg
Data codeQR Codexseerpharma.com85551-125-30_Hydroxocobalamin_1mgml_30ml_vial.jpg.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85551-12585551-125-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HydroxocobalaminHYDROXOCOBALAMINXseer Pharmaceuticals3be23e83-4a7f-3854-e063-6294a90acb7a2026-05-15Warnings, Adverse reactionsExact identifier
ndc (package): 85551-125-30
ndc (product): 85551-125
ndc11 (package): 85551012530
spl id: 51e3535b-dc11-abe8-e063-6394a90a0c61
spl set id: 3be23e83-4a7f-3854-e063-6294a90acb7a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.